Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat.

PubWeight™: 1.52‹?› | Rank: Top 4%

🔗 View Article (PMC 1854470)

Published in Br J Pharmacol on May 01, 1989

Authors

R E Buckingham1, T C Hamilton, D R Howlett, S Mootoo, C Wilson

Author Affiliations

1: Beecham Pharmaceuticals, Research Division, Medicinal Research Centre, Essex.

Articles citing this

Characterization of potassium currents modulated by BRL 38227 in rat portal vein. Br J Pharmacol (1992) 1.50

Potassium channel blockers and the effects of cromakalim on the smooth muscle of the guinea-pig bladder. Br J Pharmacol (1990) 1.41

The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim. Br J Pharmacol (1990) 1.26

Characterization of responses to cromakalim and pinacidil in smooth and cardiac muscle by use of selective antagonists. Br J Pharmacol (1990) 1.16

Differential effects of acetylcholine, nitric oxide and levcromakalim on smooth muscle membrane potential and tone in the rabbit basilar artery. Br J Pharmacol (1993) 1.14

Potassium channels and airway function: new therapeutic prospects. Thorax (1990) 1.10

Comparison of the actions of acetylcholine and BRL 38227 in the guinea-pig coronary artery. Br J Pharmacol (1992) 1.03

The involvement of potassium channels in the action of ciclazindol in rat portal vein. Br J Pharmacol (1992) 1.01

Glibenclamide is a competitive antagonist of the thromboxane A2 receptor in dog coronary artery in vitro. Br J Pharmacol (1990) 0.95

Differences in the K(+)-channels opened by cromakalim, acetylcholine and substance P in rat aorta and porcine coronary artery. Br J Pharmacol (1991) 0.95

Comparative effects of BRL 38227, nitrendipine and isoprenaline on carbachol- and histamine-stimulated phosphoinositide metabolism in airway smooth muscle. Br J Pharmacol (1992) 0.94

Pharmacology of the potassium channel openers. Cardiovasc Drugs Ther (1995) 0.93

Sulphonylureas reduce the slowly inactivating D-type outward current in rat hippocampal neurons. J Physiol (1993) 0.90

Effects of several potassium channel openers and glibenclamide on the uterus of the rat. Br J Pharmacol (1990) 0.90

Antagonism of levcromakalim by imidazoline- and guanidine-derivatives in rat portal vein: involvement of the delayed rectifier. Br J Pharmacol (1993) 0.88

Pinacidil inhibits neuromuscular transmission indirectly in the guinea-pig and rabbit mesenteric arteries. Br J Pharmacol (1990) 0.88

Evidence that pinacidil may promote the opening of ATP-sensitive K+ channels yet inhibit the opening of Ca2(+)-activated K+ channels in K(+)-contracted canine mesenteric artery. Br J Pharmacol (1990) 0.88

One way cross tolerance between cromakalim and salbutamol in the uterus of the rat in vivo. Br J Pharmacol (1992) 0.87

Effect of cromakalim and glibenclamide on spontaneous and evoked motility of the guinea-pig isolated renal pelvis and ureter. Br J Pharmacol (1994) 0.86

Comparison of the effects of the K(+)-channel openers cromakalim and minoxidil sulphate on vascular smooth muscle. Br J Pharmacol (1991) 0.85

Cytoplasmic calcium and the relaxation of canine coronary arterial smooth muscle produced by cromakalim, pinacidil and nicorandil. Br J Pharmacol (1990) 0.85

Effects of glibenclamide on systemic and splanchnic haemodynamics in conscious rats. Br J Pharmacol (1994) 0.85

Antagonism of relaxin by glibenclamide in the uterus of the rat in vivo. Br J Pharmacol (1991) 0.81

K channel openers activate different K channels in vascular smooth muscle cells. Cardiovasc Drugs Ther (1993) 0.79

The diverse effects of cromakalim on tension and 86Rb efflux in canine arterial smooth muscle. Br J Pharmacol (1991) 0.77

An analysis of the nitrate-like and K channel opening actions of KRN2391 in canine coronary arterial smooth muscle. Br J Pharmacol (1991) 0.77

Cardiovascular effects of Helichrysum ceres S Moore [Asteraceae] ethanolic leaf extract in some experimental animal paradigms. Cardiovasc J Afr (2008) 0.77

TRPA1 activation leads to neurogenic vasodilatation: involvement of reactive oxygen nitrogen species in addition to CGRP and NO. Br J Pharmacol (2016) 0.77

Proceedings of the British Pharmacological Society Meeting. 3rd-5th January 1990. Abstracts. Br J Pharmacol (1990) 0.75

Proceedings of the British Pharmacological Society. University of Manchester, 13-15 September 1989. Br J Pharmacol (1989) 0.75

Proceedings of the British Pharmacological Society Meeting. Sheffield, 18-20th April 1990. Br J Pharmacol (1990) 0.75

Characteristics of the contractile response of rabbit aorta produced by cromakalim in calcium-free solution. Br J Pharmacol (1992) 0.75

Articles cited by this

Intracellular ATP directly blocks K+ channels in pancreatic B-cells. Nature (1984) 6.06

Glucose induces closure of single potassium channels in isolated rat pancreatic beta-cells. Nature (1985) 5.52

Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol (1986) 4.75

The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels. Br J Pharmacol (1986) 3.68

Electrical and mechanical effects of BRL34915 in guinea-pig isolated trachealis. Br J Pharmacol (1986) 3.07

Glucose dependent K+-channels in pancreatic beta-cells are regulated by intracellular ATP. Pflugers Arch (1985) 2.66

Cyclic changes in potential and resistance of the beta-cell membrane induced by glucose in islets of Langerhans from mouse. J Physiol (1978) 2.11

Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells. Biochem Pharmacol (1982) 1.90

Effect of the K+ efflux stimulating vasodilator BRL 34915 on 86Rb+ efflux and spontaneous activity in guinea-pig portal vein. Br J Pharmacol (1987) 1.81

BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol (1986) 1.79

The relaxant action of BRL 34915 in rat uterus. Br J Pharmacol (1987) 1.45

Tolbutamide stimulation and inhibition of insulin release: studies of the underlying ionic mechanisms in isolated rat islets. Diabetologia (1980) 1.34

The antidiabetic sulfonylurea glibenclamide is a potent blocker of the ATP-modulated K+ channel in insulin secreting cells. Biochem Biophys Res Commun (1987) 1.27

Indwelling catheters for direct recording of arterial blood pressure and intravenous injection of drugs in the conscious rat. J Pharm Pharmacol (1976) 1.13

The control of 86Rb efflux from rat isolated pancreatic islets by the sulphonylureas tolbutamide and glibenclamide. Br J Pharmacol (1984) 0.99

Interaction of sulfonylurea with the pancreatic B-cell. Experientia (1984) 0.98

Mechanism of the stimulation of insulin release in vitro by HB 699, a benzoic acid derivative similar to the non-sulphonylurea moiety of glibenclamide. Diabetologia (1985) 0.98

Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine. Br J Pharmacol (1988) 0.95

Direct measurements of increased free cytoplasmic Ca2+ in mouse pancreatic beta-cells following stimulation by hypoglycemic sulfonylureas. FEBS Lett (1985) 0.90

[Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models]. Arzneimittelforschung (1972) 0.81

Articles by these authors

(truncated to the top 100)

Effect of general practitioners' advice against smoking. Br Med J (1979) 24.07

THE NATURE OF THE PERIPHERAL RESISTANCE IN ARTERIAL HYPERTENSION WITH SPECIAL REFERENCE TO THE VASOMOTOR SYSTEM. J Clin Invest (1936) 18.94

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol (2000) 16.83

Intercapillary Lesions in the Glomeruli of the Kidney. Am J Pathol (1936) 12.50

Antitumor activity of thalidomide in refractory multiple myeloma. N Engl J Med (1999) 11.27

A plethysmographic method for measuring systolic blood pressure in the intact rat. J Physiol (1938) 7.20

Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet (2001) 6.92

Construction and properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol (1991) 6.19

P-element-mediated enhancer detection: a versatile method to study development in Drosophila. Genes Dev (1989) 5.76

AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci U S A (1992) 5.24

Radiation survival parameters of antineoplastic drug-sensitive and -resistant human ovarian cancer cell lines and their modification by buthionine sulfoximine. Cancer Res (1985) 5.09

Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol (1986) 4.75

Benign and Malignant Hypertension and Nephrosclerosis: A Clinical and Pathological Study. Am J Pathol (1936) 4.43

Genetic evidence for the spread of agriculture in Europe by demic diffusion. Nature (1991) 4.34

A cytogenetic study of 1000 spontaneous abortions. Ann Hum Genet (1980) 3.82

Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci (1999) 3.77

Atypical beta-adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature (1984) 3.64

Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A (1997) 3.61

Inflammatory Lesions in the Glomeruli in Pyelonephritis in Relation to Hypertension and Renal Insufficiency. Am J Pathol (1936) 3.52

New world views: preparing physicians in training for global health work. Fam Med (2000) 3.23

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc Natl Acad Sci U S A (1992) 3.22

A JNK signal transduction pathway that mediates morphogenesis and an immune response in Drosophila. Genes Dev (1996) 3.21

Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene. Cell (1988) 2.91

Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res (1983) 2.90

Drosophila tumor suppressor PTEN controls cell size and number by antagonizing the Chico/PI3-kinase signaling pathway. Genes Dev (1999) 2.87

Plasma nicotine levels after smoking cigarettes with high, medium, and low nicotine yields. Br Med J (1975) 2.80

Structure of the CAP-DNA complex at 2.5 angstroms resolution: a complete picture of the protein-DNA interface. J Mol Biol (1996) 2.80

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues. Cancer Res (1987) 2.67

Comparison of effect on tobacco consumption and carbon monoxide absorption of changing to high and low nicotine cigarettes. Br Med J (1973) 2.65

RNA secondary structure prediction based on free energy and phylogenetic analysis. J Mol Biol (1999) 2.65

Effect of nicotine chewing gum on smoking behaviour and as an aid to cigarette withdrawal. Br Med J (1976) 2.41

A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain. N Engl J Med (1982) 2.28

Mobile coronary care and community mortality from myocardial infarction. Lancet (1985) 2.27

Reversal of adriamycin resistance by verapamil in human ovarian cancer. Science (1984) 2.24

Stimulation and suppression of PCR-mediated recombination. Nucleic Acids Res (1998) 2.17

Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst (1996) 2.17

Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Ther (1995) 2.11

A microtest for the quantitation of rabies virus neutralizing antibodies. J Biol Stand (1979) 2.10

The treatment and prevention of obesity: a systematic review of the literature. Int J Obes Relat Metab Disord (1997) 2.10

Improving the detection rate of early gastric cancer requires more than open access gastroscopy: a five year study. Gut (1997) 2.09

On the scale of global demographic convergence, 1950-2000. Popul Dev Rev (2001) 2.07

Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.06

Human apolipoprotein E. Role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms. J Biol Chem (1994) 2.04

HIF-1 and NF-kappaB-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene (2007) 2.00

Antibodies to proteus in rheumatoid arthritis. Lancet (1985) 1.96

Therapeutic Trial of Methionine in Infective Hepatitis. Br Med J (1945) 1.95

Acute chest pain in the emergency room. Identification and examination of low-risk patients. Arch Intern Med (1985) 1.86

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion. Biochem Pharmacol (1985) 1.86

The rat lipolytic beta-adrenoceptor: studies using novel beta-adrenoceptor agonists. Eur J Pharmacol (1984) 1.85

UV-Stimulated K Efflux from Rose Cells: Counterion and Inhibitor Studies. Plant Physiol (1982) 1.85

Comparison of increases in carboxyhaemoglobin after smoking "extra-mild" and "non-mild" cigarettes. Lancet (1973) 1.84

Perturbation of Chara Plasmalemma Transport Function by 2[4(2',4'-Dichlorophenoxy)phenoxy]propionic Acid. Plant Physiol (1984) 1.83

Spontaneous transformation of rat ovarian surface epithelial cells: association with cytogenetic changes and implications of repeated ovulation in the etiology of ovarian cancer. J Natl Cancer Inst (1992) 1.82

Variability of the lytic susceptibility of Neisseria gonorrhoeae to human sera. J Immunol (1977) 1.81

BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol (1986) 1.79

Idiopathic granulomatous mastitis. A report of three cases and review of the literature. Arch Pathol Lab Med (1994) 1.79

Characterization of the humoral immune response to Klebsiella species in inflammatory bowel disease and ankylosing spondylitis. Br J Rheumatol (1998) 1.69

GSK3: a SHAGGY frog story. Trends Cell Biol (1996) 1.65

Depletion of glutathione in normal and malignant human cells in vivo by buthionine sulfoximine: clinical and biochemical results. J Natl Cancer Inst (1992) 1.61

AKT2, a member of the protein kinase B family, is activated by growth factors, v-Ha-ras, and v-src through phosphatidylinositol 3-kinase in human ovarian epithelial cancer cells. Cancer Res (1998) 1.61

Increased antibiotic resistance of Neisseria gonorrhoeae in Korea. Antimicrob Agents Chemother (1976) 1.58

Evaluation of chromogenic meticillin-resistant Staphylococcus aureus media: sensitivity versus turnaround time. J Hosp Infect (2012) 1.58

Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells: role of ERCC1-XPF. Biochem Pharmacol (2000) 1.58

Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. Cancer Res (1988) 1.55

Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population. Hum Mol Genet (1997) 1.55

Appendicitis in pregnancy: an ongoing diagnostic dilemma. Colorectal Dis (2008) 1.54

Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women. J Am Geriatr Soc (1998) 1.53

Co-induction and laryngeal mask insertion. A comparison of thiopentone versus propofol. Anaesthesia (1997) 1.52

Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients. J Clin Oncol (1987) 1.50

2.8 A crystal structure of the malachite green aptamer. J Mol Biol (2000) 1.49

Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet (1990) 1.49

The structural basis for molecular recognition by the vitamin B 12 RNA aptamer. Nat Struct Biol (2000) 1.48

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer (2006) 1.48

Cloning, expression, and alternative splicing of the receptor for anti-Müllerian hormone. Mol Endocrinol (1994) 1.46

The biology of ovarian cancer. Semin Oncol (1998) 1.46

Targeting motifs and functional parameters governing the assembly of connexins into gap junctions. Biochem J (2000) 1.45

Defibrillators in general practice. Br Med J (Clin Res Ed) (1984) 1.45

Extended forensic evaluation when sexual abuse is suspected: a multisite field study. Child Maltreat (2001) 1.43

Is rheumatoid arthritis a form of reactive arthritis? J Rheumatol (2000) 1.42

Genes amplified and overexpressed in human multidrug-resistant cell lines. Cancer Res (1988) 1.42

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells. Br J Cancer (2005) 1.42

Trichomycosis axillaris: a different view. J Am Acad Dermatol (1989) 1.42

An advance notification letter increases participation in colorectal cancer screening. J Med Screen (2007) 1.42

Prospective comparison of clinical and echocardiographic diagnosis of rheumatic carditis: long term follow up of patients with subclinical disease. Heart (2001) 1.42

Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches. Semin Oncol (1984) 1.41

Ovarian cancer biology. Semin Oncol (1991) 1.40

Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines. Cancer Res (1997) 1.39

The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: correlation with replicative bypass of platinum-DNA adducts. Cancer Res (1998) 1.39

Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: effects of novelty, habituation, and fear. J Neurosci (1996) 1.38

Proton-assisted amino-acid transporters are conserved regulators of proliferation and amino-acid-dependent mTORC1 activation. Oncogene (2010) 1.37

1995 Standards for Acute Care Organizations not responsive to customer voices. Leadersh Health Serv (1995) 1.37

Accumulation of extracellular matrix and developmental dysregulation in the pancreas by transgenic production of transforming growth factor-beta 1. Am J Pathol (1995) 1.37

Mutations of the mitochondrial ND1 gene as a cause of MELAS. J Med Genet (2004) 1.35

Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion. Cancer Res (1984) 1.35

Metallothionein gene expression and resistance to cisplatin in human ovarian cancer. Int J Cancer (1990) 1.35

Acute superior mesenteric ischaemia. Br J Surg (1987) 1.35

A comparative study of [3H]haloperidol and [3H]spiroperidol binding to receptors on rat cerebral membranes. FEBS Lett (1978) 1.35

Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator. Comparison with nicorandil. Biochem Pharmacol (1987) 1.34

P-element-mediated enhancer detection applied to the study of oogenesis in Drosophila. Development (1989) 1.34

Laser-mediated, site-specific inactivation of RNA transcripts. Proc Natl Acad Sci U S A (1999) 1.34